EDITORIAL
Published on 30 Sep 2021
Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond
doi 10.3389/fimmu.2021.770419
- 1,644 views
- 4 citations
- Frontiers in Immunology
- Immunological Tolerance and Regulation
- Research Topics
- Key Players in Systemic Sclerosis: The Immune System and Beyond
Key Players in Systemic Sclerosis: The Immune System and Beyond
43k
Total downloads
157k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CORRECTION
Published on 27 Jul 2021
Corrigendum: The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma
doi 10.3389/fimmu.2021.737303
- 1,020 views
- 1 citation
ORIGINAL RESEARCH
Published on 17 May 2019
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
doi 10.3389/fimmu.2019.01100
- 3,056 views
- 28 citations
REVIEW
Published on 10 Jan 2019
Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
doi 10.3389/fimmu.2018.03112
- 19,293 views
- 74 citations
ORIGINAL RESEARCH
Published on 21 Dec 2018
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
doi 10.3389/fimmu.2018.03056
- 3,164 views
- 20 citations
MINI REVIEW
Published on 18 Dec 2018
Targeting Costimulatory Pathways in Systemic Sclerosis
doi 10.3389/fimmu.2018.02998
- 5,656 views
- 37 citations
REVIEW
Published on 14 Dec 2018
Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
doi 10.3389/fimmu.2018.02938
- 7,375 views
- 55 citations
ORIGINAL RESEARCH
Published on 07 Dec 2018
Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis
doi 10.3389/fimmu.2018.02835
- 3,730 views
- 14 citations
REVIEW
Published on 13 Nov 2018
Unraveling SSc Pathophysiology; The Myofibroblast
doi 10.3389/fimmu.2018.02452
- 13,046 views
- 113 citations
ORIGINAL RESEARCH
Published on 05 Nov 2018
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
doi 10.3389/fimmu.2018.02571
- 5,269 views
- 34 citations
ORIGINAL RESEARCH
Published on 02 Nov 2018
Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis
doi 10.3389/fimmu.2018.02457
- 4,462 views
- 22 citations
ORIGINAL RESEARCH
Published on 23 Oct 2018
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
doi 10.3389/fimmu.2018.02434
- 9,086 views
- 51 citations
Published in
Frontiers in Immunology
- Immunological Tolerance and Regulation
- Autoimmune and Autoinflammatory DisordersOffline
Impact
- 157kTopic views
- 112kArticle views
- 43kArticle downloads